hTid-1 interacts with EGFR/HSP70/HSP90 via its DnaJ domain and induces poly-ubiquitination resulting in subsequent proteasomal degradation of EGFR, thereby downregulating its expression levels and hence acting as a deterrent in the progression of lung adenocarcinomas [61]. Here, EGFR is linked to lung adenocarcinoma.